GeoVax Labs, Inc. has announced that Sino Biological, Inc. will be its exclusive supplier of SARS-CoV-2 (COVID-19) bioreagent research products.

Avacta has entered into a collaboration with Adeptrix to develop a high throughput COVID-19 antigen test using Adeptrix’s proprietary bead-assisted mass spectrometry platform.

Hardy Diagnostics has announced FDA EUA approval on April 24th for a new in vitro diagnostic medical device: Anti-SARS-CoV-2 Rapid Test.

TTP and ODx are collaborating to reduce the turnaround time for the assessment of suspected UTIs, reduce the use of antibiotics and provider faster access to optimal antimicrobial therapy.

Cancer informatics and digital pathology solution provider Inspirata is setting its sights on the post-COVID-19 future.

HORIBA UK Ltd, Medical has introduced a new automated digital cell morphology solution in collaboration with CellaVision to help hematology laboratories simplify and expedite the performance of blood and body fluid differentials.

Autoscribe Informatics has announced the integration of Trilogy TAPS sample planning and scheduling management software with its Matrix Gemini configurable LIMS.

To support labs pivoting to COVID-19 research, Gemini Bio is prioritizing products and services to assist its customers in cell culture, viral harvesting and transport, research tools, and analytical instruments.

ProteoGenix has announced the first Human Immune COVID-19 library for the fast discovery of potent antibodies against SARS-CoV-2.

Horizon Discovery has added two new sample formats to its cell-based OncoSpan reference standards for use in the development and validation of workflows for cancer diagnostic assays.